A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck

✍ Scribed by G. C. MacDonald; M. Rasamoelisolo; J. Entwistle; W. Cuthbert; M. Kowalski; Maureen A. Spearman; N. Glover

• Book ID: 107576742
• Publisher: Springer US
• Year: 2008
• Tongue: English
• Weight: 218 KB
• Volume: 26
• Category: Article
• ISSN: 1357-0560
• DOI: 10.1007/s12032-008-9111-x